Evidence map›Paper›PMID 32260593›Full record

ArticleInternational journal of molecular sciences2020

Conditional Up-Regulation of SERCA2a Exacerbates RyR2-Dependent Ventricular and Atrial Arrhythmias.

Bin Liu, Qing Lou, Heather Smith, Florencia Velez-Cortes, Wolfgang H Dillmann, Björn C Knollmann, Antonis A Armoundas, Sándor Györke

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Associations BetweenBiology · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. LncRNA CCRR maintains CaScience China. Life sciences · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cellular Mechanisms Underlying the Low Cardiotoxicity of Istaroxime.Journal of the American Heart Association · 2021
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Bin LiuDavis Heart and Lung Research Institute and Department of Physiology and Cell Biology, The Ohio State University, Columbus, OH 43210, USA.
Qing LouDavis Heart and Lung Research Institute and Department of Physiology and Cell Biology, The Ohio State University, Columbus, OH 43210, USA.
Heather SmithDepartment of Biological Sciences, Mississippi State University, Starkville, MS 39762, USA.
Florencia Velez-CortesDavis Heart and Lung Research Institute and Department of Physiology and Cell Biology, The Ohio State University, Columbus, OH 43210, USA.
Wolfgang H DillmannDepartment of Medicine, University of California, San Diego, CA 92093, USA.
Björn C KnollmannDivision of Clinical Pharmacology, Vanderbilt University School of Medicine, Vanderbilt, TN 37232, USA.
Antonis A ArmoundasMassachusetts General Hospital, Cardiovascular Research Center, Charlestown, MA 02129, USA.ORCID 0000-0001-5006-1547
Sándor GyörkeDavis Heart and Lung Research Institute and Department of Physiology and Cell Biology, The Ohio State University, Columbus, OH 43210, USA.
The Ohio State University · USColumbia University Irving Medical Center · USMassachusetts General Hospital · USMississippi State University · USUniversity of California San Diego · USVanderbilt University · US

Funding

CONTROLLED AND UNCONTROLLABLE CALCIUM RELEASE IN HEARTR01HL063043 · NHLBI · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI Sandor Gyorke · 1999 to 2026
$8.6M
Regulation and Dysregulation of Cardiac EC coupling by CalmodulinR01HL138579 · NHLBI · OHIO STATE UNIVERSITY · PI Jonathan Paul Davis, Sandor Gyorke · 2017 to 2026
$6.1M
American Heart Association #15GRNT23070001American Heart Association SDG 17SDG33410716NHLBI NIH HHS R01 HL063043NHLBI NIH HHS R01 HL138579NIH HHS HL063043NIH HHS HL135335-01NIH HHS HL138579NIH HHS RO1 HL074045
6 · The paper itself

Abstract

Ryanodine receptor 2 (RyR2) and SERCA2a are two major players in myocyte calcium (Ca) cycling that are modulated physiologically, affected by disease and thus considered to be potential targets for cardiac disease therapy. However, how RyR2 and SERCA2a influence each others' activities, as well as the primary and secondary consequences of their combined manipulations remain controversial. In this study, we examined the effect of acute upregulation of SERCA2a on arrhythmogenesis by conditionally overexpressing SERCA2a in a mouse model featuring hyperactive RyR2s due to ablation of calsequestrin 2 (CASQ2). CASQ2 knock-out (KO) mice were crossbred with doxycycline (DOX)-inducible SERCA2a transgenic mice to generate KO-TG mice. In-vivo ECG studies have shown that induction of SERCA2a (DOX+) overexpression markedly exacerbated both ventricular and atrial arrhythmias in vivo, compared with uninduced KO-TG mice (DOX-). Consistent with that, confocal microscopy in both atrial and ventricular myocytes demonstrated that conditional upregulation of SERCA2a enhanced the rate of occurrence of diastolic Ca release events. Additionally, deep RNA sequencing identified 17 downregulated genes and 5 upregulated genes in DOX+ mice, among which Ppp1r13l, Clcn1, and Agt have previously been linked to arrhythmias. Our results suggest that conditional upregulation of SERCA2a exacerbates hyperactive RyR2-mediated arrhythmias by further elevating diastolic Ca release.

Indexed as

Action PotentialsAnimalsArrhythmias, CardiacCalcium SignalingCalsequestrinCells, CulturedHeart AtriaHeart VentriclesMaleMiceMice, Inbred C57BLMyocytes, CardiacRyanodine Receptor Calcium Release ChannelSarcoplasmic Reticulum Calcium-Transporting ATPasesTranscriptomeUp-RegulationAtp2a2 protein, mouseCalsequestrincasq2 protein, mouseRyanodine Receptor Calcium Release ChannelSarcoplasmic Reticulum Calcium-Transporting ATPasesand ec-coupling 4arrhythmia 1calcium channel 2calcium signaling 3

Identifiers

PMID32260593
PMCPMC7178036
OpenAlexW3014311835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.